Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 26.70% is in line with its 5-year average of 25.69%, around the middle of its 5-year range (14.98%–32.79%).
1.07% below its 12-month average of 26.99%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 25.50%.
NET PROFIT MARGIN
26.70%
NET PROFIT MARGIN AVG TTM
26.99%
NET PROFIT MARGIN AVG 3Y
26.32%
NET PROFIT MARGIN AVG 5Y
25.69%
NET PROFIT MARGIN AVG 10Y
23.22%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-1.07%
CURRENT VS 3Y AVG
+1.44%
CURRENT VS 5Y AVG
+3.93%
CURRENT VS 10Y AVG
+15.00%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.04%
median of 850 covered companies
CURRENT VS SECTOR MEDIAN
+66850.00%
vs the sector median at left
IRadimed Corporation
Market Cap
$1.08B
Net Profit Margin
26.70%
TTM Avg
26.99%
3Y Avg
26.32%
5Y Avg
25.69%
Market Cap
$1.09B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.10B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.11B
Net Profit Margin
1.13%
TTM Avg
-33.60%
3Y Avg
-11.14%
5Y Avg
-1.51%
Market Cap
$1.11B
Net Profit Margin
-12.40%
TTM Avg
-22.32%
3Y Avg
-24.80%
5Y Avg
-16.46%
Market Cap
$1.11B
Net Profit Margin
-6.08%
TTM Avg
-15.19%
3Y Avg
-17.99%
5Y Avg
-12.77%
Market Cap
$1.11B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.05B
Net Profit Margin
-7.13%
TTM Avg
-23.45%
3Y Avg
-155.72%
5Y Avg
-114.72%
Market Cap
$1.14B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IRadimed Corporation (IRMD) | $1.08B | 26.70% | 26.99% | 26.32% | 25.69% |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.09B | 0.00% | 0.00% | 0.00% | 0.00% |
| First Tracks Biotherapeutics Inc (TRAX)vs › | $1.10B | 0.00% | 0.00% | 0.00% | 0.00% |
| STAAR Surgical Company (STAA)vs › | $1.11B | 1.13% | -33.60% | -11.14% | -1.51% |
| OPKO Health, Inc. (OPK)vs › | $1.11B | -12.40% | -22.32% | -24.80% | -16.46% |
| Tandem Diabetes Care, Inc. (TNDM)vs › | $1.11B | -6.08% | -15.19% | -17.99% | -12.77% |
| Replimune Group, Inc. (REPL)vs › | $1.11B | 0.00% | 0.00% | 0.00% | 0.00% |
| Teladoc Health, Inc. (TDOC)vs › | $1.05B | -7.13% | -23.45% | -155.72% | -114.72% |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.14B | 0.00% | 0.00% | 0.00% | 0.00% |
| Castle Biosciences, Inc. (CSTL)vs › | $1.04B | -5.43% | -0.76% | -19.17% | -21.06% |
Operating Margin
31.9%
Net Profit Margin
26.7%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 25.50% |
| 2026-03-31 | 26.47% |
| 2025-12-31 | 28.39% |
| 2025-09-30 | 26.30% |
| 2025-06-30 | 28.29% |
| 2025-03-31 | 24.02% |
| 2024-12-31 | 26.54% |
| 2024-09-30 | 27.55% |
| 2024-06-30 | 27.34% |
| 2024-03-31 | 23.51% |
| 2023-12-31 | 26.01% |
| 2023-09-30 | 30.70% |
| 2023-06-30 | 25.91% |
| 2023-03-31 | 22.01% |
| 2022-12-31 | 24.72% |
| 2022-09-30 | 25.56% |
| 2022-06-30 | 25.48% |
| 2022-03-31 | 20.20% |
| 2021-12-31 | 32.79% |
| 2021-09-30 | 23.62% |
| 2021-06-30 | 14.98% |
| 2021-03-31 | 15.04% |
| 2020-12-31 | 7.46% |
| 2020-09-30 | 13.96% |
| 2020-06-30 | -31.09% |
| 2020-03-31 | 20.39% |
| 2019-12-31 | 29.77% |
| 2019-09-30 | 24.64% |
| 2019-06-30 | 22.64% |
| 2019-03-31 | 21.87% |
| 2018-12-31 | 20.47% |
| 2018-09-30 | 31.52% |
| 2018-06-30 | 18.37% |
| 2018-03-31 | 11.83% |
| 2017-12-31 | 2.74% |
| 2017-09-30 | 3.38% |
| 2017-06-30 | 6.46% |
| 2017-03-31 | -4.52% |
| 2016-12-31 | 19.04% |
| 2016-09-30 | 20.34% |
| 2016-06-30 | 22.61% |
| 2016-03-31 | 25.46% |
| 2015-12-31 | 27.33% |
| 2015-09-30 | 22.79% |
| 2015-06-30 | 23.27% |
| 2015-03-31 | 21.28% |
| 2014-12-31 | 7.56% |
| 2014-09-30 | 6.23% |
| 2014-06-30 | 21.68% |
| 2014-03-31 | 14.71% |
| 2013-12-31 | 13.71% |
| 2013-09-30 | 10.51% |
| 2013-06-30 | 20.12% |
| 2013-03-31 | 24.50% |
